Globes
Thursday 31st October, 2013
Moscow City Department of Healthcare: Teva has halted deliveries of Carboplatin, a generic cancer treatment. Teva said in response: Teva is committed to the Russian market and its patients, and continues to supply all its products to this market, as normal.
Read the full story at Globes